Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02684292
Brief Title: Study of Pembrolizumab (MK-3475) vs. Brentuximab Vedotin in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-204/KEYNOTE-204)

First Submitted : February 12, 2016
First Submitted that Met QC Criteria : February 12, 2016
First Posted : February 17, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : August 3, 2020
Last Update Posted : August 4, 2020